{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:15:50Z","timestamp":1778710550462,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1986,9,1]],"date-time":"1986-09-01T00:00:00Z","timestamp":525916800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother. Pharmacol."],"published-print":{"date-parts":[[1986,9]]},"DOI":"10.1007\/bf00253068","type":"journal-article","created":{"date-parts":[[2004,10,3]],"date-time":"2004-10-03T17:37:35Z","timestamp":1096825055000},"page":"69-73","source":"Crossref","is-referenced-by-count":71,"title":["Cumulative renal tubular damage associated with cisplatin nephrotoxicity"],"prefix":"10.1007","volume":"18","author":[{"given":"Marshall P.","family":"Goren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reba K.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc E.","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00000441-198507000-00003","volume":"290","author":"BH Brouhard","year":"1985","unstructured":"Brouhard BH, Lagrone L, Rowe J (1985) Acute response of urinary N-acetyl-?-D-glucosaminidase to mannitol infusion in the dog. Am J Med Sci 290: 11","journal-title":"Am J Med Sci"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF00254051","volume":"8","author":"PK Buamah","year":"1982","unstructured":"Buamah PK, Howell A, Whitby H, Harpur ES, Gescher A (1982) Assessment of renal function during high-dose cis-platinum therapy in patients with ovarian carcinoma. Cancer Chemother Pharmacol 8: 281","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1001\/archinte.1984.00350220063013","volume":"144","author":"JE Buckley","year":"1984","unstructured":"Buckley JE, Clark VL, Meyer TJ, Pearlman NW (1984) Hypomagnesemia after cisplatin combination chemotherapy. Arch Intern Med 144: 2347","journal-title":"Arch Intern Med"},{"key":"CR4","first-page":"1235","volume":"73","author":"RE Bulger","year":"1984","unstructured":"Bulger RE, Dobyan DC (1984) Proliferative lesions found in rat kidneys after a single dose of cisplatin. JNCI 73: 1235","journal-title":"JNCI"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/4.3.217","volume":"4","author":"MS Burstone","year":"1956","unstructured":"Burstone MS, Folk JE (1956) Histochemical demonstration of aminopeptidase. J Histochem Cytochem 4: 217","journal-title":"J Histochem Cytochem"},{"key":"CR6","first-page":"658","volume":"99","author":"FA Carone","year":"1975","unstructured":"Carone FA, Ganote CE (1975) D-Serine nephrotoxicity. The nature of proteinuria, glucosuria and aminoaciduria in acute tubular necrosis. Arch Pathol 99: 658","journal-title":"Arch Pathol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/1097-0142(19830715)52:2<211::AID-CNCR2820520205>3.0.CO;2-U","volume":"52","author":"D Chiuten","year":"1983","unstructured":"Chiuten D, Vogl S, Kaplan B, Camacho F (1983) Is there cumulative or delayed toxicity from cisplatinum? Cancer 52: 211","journal-title":"Cancer"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/1097-0142(197804)41:4<1274::AID-CNCR2820410410>3.0.CO;2-F","volume":"41","author":"M Dentino","year":"1978","unstructured":"Dentino M, Luft FC, Yum MN, Williams SD, Einhorn LH (1978) Long-term effect of cis-diamminedichloride platinum (CDDP) on renal function and structure in man. Cancer 41: 1274","journal-title":"Cancer"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0009-8981(81)90373-9","volume":"112","author":"U Diener","year":"1981","unstructured":"Diener U, Knoll E, Langer B, Rautenstrauch H, Ratge D, Wisser H (1981) Urinary excretion of N-acetyl-?-D-glucos-aminidase and alanine aminopeptidase in patients receiving amikacin or cis-platinum. Clin Chim Acta 112: 149","journal-title":"Clin Chim Acta"},{"key":"CR10","first-page":"615","volume":"20","author":"U Diener","year":"1982","unstructured":"Diener U, Knoll E, Ratge D, Langer B, Wisser H (1982) Urinary excretion of alanine aminopeptidase and N-acetyl-?-D-glucosaminidase during sequential combination chemotherapy. J Clin Chem Clin Biochem 20: 615","journal-title":"J Clin Chem Clin Biochem"},{"key":"CR11","first-page":"551","volume":"213","author":"DC Dobyan","year":"1980","unstructured":"Dobyan DC, Levi J, Jacobs C, Kosek J, Weiner MW (1980) Mechanism of cis-platinum nephrotoxicity: II. Morphologic observations. J Pharmacol Exp Ther 213: 551","journal-title":"J Pharmacol Exp Ther"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0277-5379(85)90033-1","volume":"21","author":"G Giaccone","year":"1985","unstructured":"Giaccone G, Donadio M, Ferrati P, Ciuffreda L, Bagatella M, Gaddi M, Calciati A (1985) Disorders of serum electrolytes and renal function in patients treated with cis-platinum on an outpatient basis. Eur J Cancer Clin Oncol 21: 433","journal-title":"Eur J Cancer Clin Oncol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/1097-0142(197704)39:4<1362::AID-CNCR2820390403>3.0.CO;2-N","volume":"39","author":"JC Gonzalez-Vitale","year":"1977","unstructured":"Gonzalez-Vitale JC, Hayes DM, Cvitokovic E, Sternberg SS (1977) The renal pathology in clinical trials of cis-platinum(II) diamminedichloride. Cancer 39: 1362","journal-title":"Cancer"},{"key":"CR14","first-page":"693","volume":"62","author":"JC Gonzalez-Vitale","year":"1978","unstructured":"Gonzalez-Vitale JC, Hayes DM, Cvitokovic E, Sternberg SS (1978) Acute renal failure after cis-dichlorodiammineplatinum (II) and gentamicin-cephalothin therapies. Cancer Treat Rep 62: 693","journal-title":"Cancer Treat Rep"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/clinchem\/32.2.386","volume":"32","author":"MP Goren","year":"1986","unstructured":"Goren MP, Li JTL (1986) The Coomassie brilliant blue method understimates drug-induced tubular proteinuria. Clin Chem 32: 386","journal-title":"Clin Chem"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0002-9343(82)90748-3","volume":"73","author":"RM Harrell","year":"1982","unstructured":"Harrell RM, Sibley R, Volgelzang NJ (1982) Renal vascular lesions after chemotherapy with vinblastine, bleomycin, and cisplatin. Am J Med 73: 429","journal-title":"Am J Med"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/1097-0142(197704)39:4<1372::AID-CNCR2820390404>3.0.CO;2-J","volume":"39","author":"DM Hayes","year":"1977","unstructured":"Hayes DM, Cvitkovic E, Golbey RB, Scheiner E, Helson L, Krakoff IH (1977) High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis. Cancer 39: 1372","journal-title":"Cancer"},{"key":"CR18","first-page":"547","volume":"63","author":"FA Hayes","year":"1979","unstructured":"Hayes FA, Green AA, Senzer N, Pratt CB (1979) Tetany: A complication of cis-dichlorodiammineplatinum(II) therapy. Cancer Treat Rep 63: 547","journal-title":"Cancer Treat Rep"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/clinchem\/27.7.1180","volume":"7","author":"E Horak","year":"1981","unstructured":"Horak E, Hopfer SM, Sunderman FW Jr (1981) Spectrophotometric assay for urinary N-acetyl-?-D-glucosaminidase. Clin Chem 7: 1180","journal-title":"Clin Chem"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0002-9343(84)90280-8","volume":"76","author":"WJM Hrushesky","year":"1984","unstructured":"Hrushesky WJM, Shimp W, Kennedy BJ (1984) Lack of age-dependent cisplatin nephrotoxicity. Am J Med 76: 579","journal-title":"Am J Med"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/clpt.1980.79","volume":"27","author":"BR Jones","year":"1980","unstructured":"Jones BR, Bhalla RB, Mladek J, Kaleya RN, Gralla RJ, Alcock NW, Schwartz MK, Young CW, Reidenberg MM (1980) Comparison of methods of evaluating nephrotoxicity of cis-platinum. Clin Pharmacol Ther 27: 557","journal-title":"Clin Pharmacol Ther"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1203\/00006450-198601000-00003","volume":"20","author":"HTM Jongejan","year":"1986","unstructured":"Jongejan HTM, Provoost AP, Wolff ED, Molenaar JC (1986) Nephrotoxicity of cis-platin comparing young and adult rats. Pediatr Res 20: 9","journal-title":"Pediatr Res"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/clinchem\/26.9.1251","volume":"26","author":"K Jung","year":"1980","unstructured":"Jung K, Scholz D (1980) An optimized assay of alanine aminopeptidase activity in urine. Clin Chem 26: 1251","journal-title":"Clin Chem"},{"key":"CR24","first-page":"835","volume":"61","author":"P Kamalakar","year":"1977","unstructured":"Kamalakar P, Freeman AI, Higby OJ, Wallace HJ Jr, Sinks LF (1977) Clinical response and toxicity with cis-dichlorodiammine platinum (II) in children. Cancer Treat Rep 61: 835","journal-title":"Cancer Treat Rep"},{"key":"CR25","first-page":"1083","volume":"64","author":"JA Kuhn","year":"1980","unstructured":"Kuhn JA, Argy WP, Rakowski TA, Moriarty JK Jr, Shreiner GE, Schein PS (1980) Nephrotoxicity of cis-diamminedichloroplatinum (II) as measured by urinary ?-glucuronidase. Cancer Treat Rep 64: 1083","journal-title":"Cancer Treat Rep"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/mpo.2950120219","volume":"12","author":"J Kurtzberg","year":"1984","unstructured":"Kurtzberg J, Dennis VW, Kinney TR (1984) Cisplatinum-induced renal salt wasting. Med Pediatr Oncol 12: 150","journal-title":"Med Pediatr Oncol"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00644546","volume":"63","author":"M Hir Le","year":"1979","unstructured":"Le Hir M, Dubach UC, Schmidt U (1979) Quantitative distribution of lysosomal hydrolases in the rat nephron. Histochemistry 63: 245","journal-title":"Histochemistry"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0002-9343(78)90825-2","volume":"65","author":"NE Madias","year":"1978","unstructured":"Madias NE, Harrington JT (1978) Platinum nephrotoxicity Am J Med 65: 307","journal-title":"Am J Med"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-96-2-257_1","volume":"96","author":"M Markman","year":"1982","unstructured":"Markman M, Trump DL (1982) Nephrotoxicity with cisplatin and antihypertensive medications. Ann Intern Med 96: 257","journal-title":"Ann Intern Med"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF00292867","volume":"8","author":"S Meijer","year":"1982","unstructured":"Meijer S, Mulder NH, Sleijfer DT, de Jong PE, Sluiter WJ, Koops HS, van der Hem GK (1982) Nephrotoxicity of cis-diamminedichloride platinum (CDDP) during remission-induction and maintenance chemotherapy of testicular carcinoma. Cancer Chemother Pharmacol 8: 27","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/1097-0142(19830601)51:11<2035::AID-CNCR2820511113>3.0.CO;2-8","volume":"51","author":"S Meijer","year":"1983","unstructured":"Meijer S, Sleijfer DT, Mulder NH, Sluiter WJ, Marrink J, Koops HS, Brouwers TM, Oldhoff J, van der Hem GK, Mandema E (1983) Some effects of combination chemotherapy with cis-platinum on renal function in patients with nonseminomatous testicular carcinoma. Cancer 51: 2035","journal-title":"Cancer"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1200\/JCO.1985.3.9.1246","volume":"3","author":"RF Ozols","year":"1985","unstructured":"Ozols RF, Ostchega Y, Myers CE, Young RC (1985) High-dose cisplatin in hypertonic saline in refractory ovarian cancer. J Clin Oncol 3: 1246","journal-title":"J Clin Oncol"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF00263886","volume":"15","author":"L Pendyala","year":"1985","unstructured":"Pendyala L, Madajewicz S, Lele SB, Arbuck SG, Creaven PJ (1985) Evaluation of the nephrotoxicity of iproplatin (CHIP) in comparison to cisplatin by the measurement of urinary enzymes. Cancer Chemother Pharmacol 15: 203","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR34","first-page":"1269","volume":"39","author":"MF Pera Jr","year":"1979","unstructured":"Pera MF Jr, Zook BC, Harder HC (1979) Effects of mannitol or furosemide diuresis on the nephrotoxicity and physiological disposition of cis-dichlorodiammineplatinum-(II) in rats. Cancer Res 39: 1269","journal-title":"Cancer Res"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/1097-0142(197212)30:6<1451::AID-CNCR2820300606>3.0.CO;2-Q","volume":"30","author":"AH Rossof","year":"1972","unstructured":"Rossof AH, Slayton RE, Perlia CP (1972) Preliminary clinical experience with cis-diamminedichloroplatinum II (NSC-119875, CACP). Cancer 30: 1451","journal-title":"Cancer"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"929","DOI":"10.7326\/0003-4819-90-6-929","volume":"90","author":"RL Schilsky","year":"1979","unstructured":"Schilsky RL, Anderson T (1979) Hypomagnesemia and renal magnesium wasting in patients receiving cisplatin. Ann Intern Med 90: 929","journal-title":"Ann Intern Med"},{"key":"CR37","first-page":"1767","volume":"66","author":"RL Schilsky","year":"1982","unstructured":"Schilsky RL, Barlock A, Ozols RF (1982) Persistent hypomagnesemia following cisplatin chemotherapy for testicular cancer. Cancer Treat Rep 66: 1767","journal-title":"Cancer Treat Rep"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1542\/peds.58.2.259","volume":"58","author":"GJ Schwartz","year":"1976","unstructured":"Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatr 58: 259","journal-title":"Pediatr"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF00258126","volume":"14","author":"PG Sorensen","year":"1985","unstructured":"Sorensen PG, Nissen MH, Groth S, Roth M (1985), Beta-2-microglobulin excretion: An indicator of long-term nephrotoxicity during cis-platinum treatment?. Cancer Chemother Pharmacol 14: 247","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1200\/JCO.1985.3.9.1251","volume":"3","author":"DJ Stewart","year":"1985","unstructured":"Stewart DJ, Mikhael NZ, Nanji AA, Nair RC, Kacew S, Howard K, Hirte W, Maroun JA (1985) Renal and hepatic concentrations of platinum: Relationship to cisplatin time, dose, and nephrotoxicity. J Clin Oncol 3: 1251","journal-title":"J Clin Oncol"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF00544087","volume":"29","author":"AS Tirelli","year":"1985","unstructured":"Tirelli AS, Colombo N, Cavanna G, Mangioni C, Assael BM (1985) Follow-up study of enzymuria and ?2 microglobulinuria during cis-platinum treatment. Eur J Clin Pharmacol 29: 313","journal-title":"Eur J Clin Pharmacol"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0022-3476(85)80098-6","volume":"106","author":"RB Womer","year":"1985","unstructured":"Womer RB, Pritchard J, Barratt TM (1985) Renal toxicity of cisplatin in children. J Pediatr 106: 659","journal-title":"J Pediatr"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00253068.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00253068\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00253068","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T12:18:52Z","timestamp":1682770732000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00253068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,9]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1986,9]]}},"alternative-id":["BF00253068"],"URL":"https:\/\/doi.org\/10.1007\/bf00253068","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986,9]]}}}